2019
DOI: 10.1007/s11684-018-0667-3
|View full text |Cite
|
Sign up to set email alerts
|

Histone variants: critical determinants in tumour heterogeneity

Abstract: Malignant cell transformation could be considered as a series of cell reprogramming events driven by oncogenic transcription factors and upstream signalling pathways. Chromatin plasticity and dynamics are critical determinants in the control of cell reprograming. An increase in chromatin dynamics could therefore constitute an essential step in driving oncogenesis and in generating tumour cell heterogeneity, which is indispensable for the selection of aggressive properties, including the ability of cells to dis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 16 publications
(8 citation statements)
references
References 58 publications
(85 reference statements)
0
8
0
Order By: Relevance
“…These processes are most likely upregulated in tissue remodelling following radiation treatment [ 33 , 34 ]. The linker histone H1 is of particular interest as it also seems to be implicated in diseases such as cancer [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…These processes are most likely upregulated in tissue remodelling following radiation treatment [ 33 , 34 ]. The linker histone H1 is of particular interest as it also seems to be implicated in diseases such as cancer [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, H2B1O and H2B1D were identified to be upregulated in WaGa, and H2B1C, H2B1K, H2B2F and H2AJ in MCC13. The role of histone variants in the development of carcinomas has been discussed and described in a number of publications [3946]. As described in a recent review, canonical histones can be replaced with variant histones after environmental-stress-induced DNA damage repair, which subsequently results in a change in chromatin structure and stability [47].…”
Section: Resultsmentioning
confidence: 99%
“…Thus, Table 16 shows a randomly selected list of up-regulated pathways and hence proteins found to be common across 2-5 cell lines. It is noteworthy from the clinical data, i.e., elevated expression of these genes at the primary tumor, was associated with both a poor survival (e.g., Fig 9: FLNB [49] and H1F0 [50] genes) as well as an enhanced or better survival (e.g., CDC42 & HLA-A, lower portion of Table 16). Thus, this analysis indicates that an overexpression of proteins at metastatic sites, relative to primary tumor levels as well as, from the clinical data, relative to normal breast tissue levels rather than normal tissue of origin levels can complicate/ contradict the interpretation of disease free survival.…”
Section: Plos Onementioning
confidence: 97%